Table 15.
L1 | L2 | L3 | L4 | Supports |
---|---|---|---|---|
CXCL10+ [23] | IFIT2+ [38] | ZNF710- | FECH+ [39] | 95% (19/20) |
BPGM+ [40] | 95% (19/20) | |||
SNCA+ [41] | 95% (19/20) | |||
SELENBP1+ [42] | 95% (19/20) | |||
HBZ+ | FECH+ [39] | 95% (19/20) | ||
BPGM+ [40] | 95% (19/20) | |||
SNCA+ [41] | 95% (19/20) | |||
SELENBP1+ [42] | 100% (20/20) | |||
TRIM46+ | 95% (19/20) | |||
SELENBP1+ [42] | HBZ+ | 95% (19/20) | ||
SELENBP1+ [42] | 95% (19/20) | |||
PPP4R4+ | SELENBP1+ [42] | 95% (19/20) | ||
IFIT2+ [38] | IFIT2+ [38] | ZNF710- | FECH+ [39] | 95% (19/20) |
BPGM+ [40] | 95% (19/20) | |||
SNCA+ [41] | 95% (19/20) | |||
SELENBP1+ [42] | 95% (19/20) | |||
HBZ+ | FECH+ [39] | 95% (19/20) | ||
BPGM+ [40] | 95% (19/20) | |||
SNCA+ [41] | 95% (19/20) | |||
SELENBP1+ [42] | 100% (20/20) | |||
TRIM46+ | 95% (19/20) | |||
SELENBP1+ [42] | HBZ+ | 95% (19/20) | ||
SELENBP1+ [42] | 95% (19/20) | |||
PPP4R4+ | SELENBP1+ [42] | 95% (19/20) | ||
TNFSF10+ [43] | IFIT2+ [38] | HBZ+ | SELENBP1+ [42] | 95% (19/20) |
[]: hepatitis C-associated genes reported in previous literature; In: the nth item in a CTGR-SP; +: expressed genes; -: repressed genes.